Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ADIL

Adial Pharmaceuticals Inc

May 05 • 04:00PM ET

1.60

0.00 0.00 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: AVXL ALDX FLNA PLX APLT ONCY HOOK GNPX LCTX XBIO

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-16.95	Insider Own	1.44%	Shs Outstand	1.43M	Perf Week	2.56%
Market Cap	2.28M	Forward P/E	-	EPS next Y	-2.59	Insider Trans	0.00%	Shs Float	1.41M	Perf Month	-8.57%
Enterprise Value	-3.60M	PEG	-	EPS next Q	-2.73	Inst Own	9.91%	Short Float	3.48%	Perf Quarter	-69.71%
Income	-7.98M	P/S	-	EPS this Y	48.74%	Inst Trans	1.92%	Short Ratio	0.43	Perf Half Y	-81.69%
Sales	0.00M	P/B	0.34	EPS next Y	57.65%	ROA	-134.29%	Short Interest	0.05M	Perf YTD	-70.91%
Book/sh	4.75	P/C	0.39	EPS next 5Y	48.08%	ROE	-170.73%	52W High	18.90 -91.53%	Perf Year	-90.72%
Cash/sh	4.13	P/FCF	-	EPS past 3/5Y	88.55% 53.46%	ROIC	-151.18%	52W Low	1.51 5.96%	Perf 3Y	-99.17%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	4.55% 5.33%	Perf 5Y	-99.89%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	80.49%	Oper. Margin	-	ATR (14)	0.10	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.42	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	40.59	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	4.42	EPS Q/Q	77.53%	SMA20	0.98%	Beta	1.26	Target Price	25.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-10.88%	Rel Volume	0.52	Prev Close	1.60
Employees	6	LT Debt/Eq	0.00	Earnings	Mar 06 AMC	SMA200	-74.91%	Avg Volume	113.39K	Price	1.60
IPO	Jul 27, 2018	Option/Short	No / Yes	EPS/Sales Surpr.	15.02% -	Trades		Volume	58,737	Change	0.00%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)